These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3100735)

  • 1. Radiation absorbed dose from technetium-99m DTPA.
    Smith T; Zanelli GD; Veall N
    J Nucl Med; 1987 Feb; 28(2):240-3. PubMed ID: 3100735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation doses from technetium-99m DTPA administered as an aerosol.
    Barber RW
    J Nucl Med; 1985 Oct; 26(10):1190-4. PubMed ID: 3900308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose to bladder wall following the administration of 99mTc-microspheres and 99mTc-DTPA.
    Smith T
    Health Phys; 1981 Nov; 41(5):777-80. PubMed ID: 7033184
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiation absorbed dose from Tc-99m diethylenetriaminepentaacetic acid (DTPA).
    Thomas SR; Atkins HL; McAfee JG; Blaufox MD; Fernandez M; Kirchner PT; Reba RC
    J Nucl Med; 1984 Apr; 25(4):503-5. PubMed ID: 6400025
    [No Abstract]   [Full Text] [Related]  

  • 6. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
    J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
    Breitz HB; Wendt RE; Stabin MS; Shen S; Erwin WD; Rajendran JG; Eary JF; Durack L; Delpassand E; Martin W; Meredith RF
    J Nucl Med; 2006 Mar; 47(3):534-42. PubMed ID: 16513624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. Task Group of the MIRD Committee, Society of Nuclear Medicine.
    Thomas SR; Stabin MG; Chen CT; Samaratunga RC
    J Nucl Med; 1999 Apr; 40(4):102S-123S. PubMed ID: 10210232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorbed radiation dose in adults from iodine-131 and iodine-123 orthoiodohippurate and technetium-99m DTPA renography.
    Carlsen O
    J Nucl Med; 1988 Mar; 29(3):400-6. PubMed ID: 3279170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m DTPA uptake and transit in bone: effect on blood clearance in rabbits.
    Sampson WF
    J Nucl Med; 1987 Sep; 28(9):1461-4. PubMed ID: 3305806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Radiation absorbed dose from Tc-99m diethylenetriaminepentaacetic acid (DTPA).
    Smith T
    J Nucl Med; 1984 Dec; 25(12):1392. PubMed ID: 6389795
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary radiation dosimetry of a novel PET radiopharmaceutical
    Cheki M; Gali H
    Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents.
    Brown PH; Krishnamurthy GT; Bobba VR; Kingston E; Turner FE
    J Nucl Med; 1982 Nov; 23(11):1025-30. PubMed ID: 6897074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease.
    Casellas F; Aguadé S; Soriano B; Accarino A; Molero J; Guarner L
    Am J Gastroenterol; 1986 Sep; 81(9):767-70. PubMed ID: 3529937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects.
    Robins PD; Salazar I; Forstrom LA; Mullan BP; Hung JC
    J Nucl Med; 2000 May; 41(5):934-40. PubMed ID: 10809211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological distribution and excretion of DTPA labeled with Tc-99m and In-111.
    McAfee JG; Gagne G; Atkins HL; Kirchner PT; Reba RC; Blaufox MD; Smith EM
    J Nucl Med; 1979 Dec; 20(12):1273-8. PubMed ID: 536795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient dosimetry of intravenously administered 99mTc-annexin V.
    Kemerink GJ; Liem IH; Hofstra L; Boersma HH; Buijs WC; Reutelingsperger CP; Heidendal GA
    J Nucl Med; 2001 Feb; 42(2):382-7. PubMed ID: 11216539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIRD dose estimate report no. 16: radiation absorbed dose from technetium-99m-diethylenetriaminepentaacetic acid aerosol.
    Atkins HL; Weber DA; Susskind H; Thomas SR
    J Nucl Med; 1992 Sep; 33(9):1717-9. PubMed ID: 1517853
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication.
    Russell CD; Bischoff PG; Rowell KL; Kontzen F; Lloyd LK; Tauxe WN; Dubovsky EV
    J Nucl Med; 1983 Aug; 24(8):722-7. PubMed ID: 6348219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.